MIRA PHARMACEUTICALS, INC. - 8-K Filing
Mira Pharmaceuticals appointed Andriy Mushak as fractional Chief Financial Officer effective June 6, 2026. Alan Weichselbaum is no longer serving as CFO; his departure was not due to disagreements with the company. Mushak will be paid $6,000 per month by Mira through LMAM Consulting Group. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits (d) Exhibits 10)
Tickers: $MIRA